AlzChem Group AG Stock
Price
Target price
€136.00
€136.00
-4.480%
-6.4
-4.480%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock AlzChem Group AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for AlzChem
sharewise wants to provide you with the best news and tools for AlzChem, so we directly link to the best financial data sources.
Financials
News
EQS-News: Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors
EQS-News: Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG: Investment program of around 120 million euros approved for further capacity expansion in creatine products
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG: Investment program of around 120 million euros approved for further capacity expansion in creatine products
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 12th Interim Report, also Final Report
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 12th Interim Report, also Final Report
EQS-News: Successful nine-month results for 2025: Alzchem Group AG increases EBITDA by 12% and confirms forecast for record year in 2025
EQS-News: Successful nine-month results for 2025: Alzchem Group AG increases EBITDA by 12% and confirms forecast for record year in 2025
Alzchem Group AG and Ehrmann launch cooperation: New high-protein creatine products with Creavitalis® available in stores from October
Alzchem Group AG and Ehrmann launch cooperation: New high-protein creatine products with Creavitalis® available in stores from October
Alzchem Group AG remains in the game: Creapure® and FC Bayern Basketball continue their collaboration in the upcoming season
Alzchem Group AG remains in the game: Creapure® and FC Bayern Basketball continue their collaboration in the upcoming season
EQS-News: Alzchem Group AG continues growth trajectory in the first half of 2025 – forecast for the full year confirmed
EQS-News: Alzchem Group AG continues growth trajectory in the first half of 2025 – forecast for the full year confirmed
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 11th interim report
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 11th interim report
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 10th interim report
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 10th interim report